CNPAX
Price
$73.46
Change
+$0.79 (+1.09%)
Updated
Oct 20 closing price
Net Assets
162.86B
MLNSX
Price
$27.65
Change
+$0.24 (+0.88%)
Updated
Oct 20 closing price
Net Assets
349.59M
Interact to see
Advertisement

CNPAX vs MLNSX

Header iconCNPAX vs MLNSX Comparison
Open Charts CNPAX vs MLNSXBanner chart's image
American Funds New Perspective 529A
Price$73.46
Change+$0.79 (+1.09%)
VolumeN/A
Net Assets162.86B
Morgan Stanley Instl Glbl Concntr R6
Price$27.65
Change+$0.24 (+0.88%)
VolumeN/A
Net Assets349.59M
CNPAX vs MLNSX Comparison Chart in %
View a ticker or compare two or three
VS
CNPAX vs. MLNSX commentary
Oct 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNPAX is a Hold and MLNSX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CNPAX has more cash in the bank: 163B vs. MLNSX (350M). CNPAX pays higher dividends than MLNSX: CNPAX (0.46) vs MLNSX (0.20). CNPAX was incepted earlier than MLNSX: CNPAX (24 years) vs MLNSX (9 years). MLNSX (9.05) is less costly to investors than CNPAX (0.77). MLNSX is a more actively managed with annual turnover of: 43.00 vs. CNPAX (24.00). CNPAX has a lower initial minimum investment than MLNSX: CNPAX (250) vs MLNSX (5000000). CNPAX (13.35) and MLNSX (13.19) have marching annual gain over last year. MLNSX return over 5 years is better than : 76.04 vs. CNPAX (38.56).
CNPAXMLNSXCNPAX / MLNSX
Total Expense Ratio0.770.9581%
Annual Report Gross Expense Ratio0.779.059%
Fund Existence24 years9 years-
Gain YTD20.36716.787121%
Front Load4%N/A-
Min. Initial Investment25050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets163B350M46,571%
Annual Yield % from dividends0.460.20236%
Returns for 1 year13.3513.19101%
Returns for 3 years63.79103.0462%
Returns for 5 years38.5676.0451%
Returns for 10 years104.38N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MOV18.931.06
+5.93%
Movado Group
CLDX27.670.84
+3.13%
Celldex Therapeutics
OVV36.270.30
+0.83%
Ovintiv
DMAAU10.48-0.02
-0.19%
Drugs Made In America Acquisition Corp
BYFC6.75-0.18
-2.57%
Broadway Financial Corp